National Cancer Institute; Notice of Closed Meetings, 33530 [2015-14342]
Download as PDF
mstockstill on DSK4VPTVN1PROD with NOTICES
33530
Federal Register / Vol. 80, No. 113 / Friday, June 12, 2015 / Notices
Place: The Lucerne Hotel, 201 West 79th
Street, New York, NY 10024.
Name of Committee: Nitsa Rosenzweig,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4152,
MSC 7760, Bethesda, MD 20892, (301) 404–
7419, rosenzweign@csr.nih.gov.
Name of Committee: AIDS and Related
Research Integrated Review Group, AIDS
Molecular and Cellular Biology Study
Section.
Date: July 15, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Melrose Hotel, 2430 Pennsylvania
Ave. NW, Washington, DC 20037.
Contact Person: Kenneth A Roebuck, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5214,
MSC 7852, Bethesda, MD 20892, (301) 435–
1166, roebuckk@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PAR Panel:
Multidisciplinary Studies of HIV/AIDS and
Aging.
Date: July 15, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Robert Freund, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5216,
MSC 7852, Bethesda, MD 20892, 301–435–
1050, freundr@csr.nih.gov.
Name of Committee:Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Child Psychopathology and
Developmental Disabilities.
Date: July 15, 2015.
Time: 1:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Serena Chu, Ph.D.,
Scientific Review Officer, BBBP IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3178,
MSC 7848, Bethesda, MD 20892, 301–500–
5829, sechu@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 8, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–14341 Filed 6–11–15; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
19:05 Jun 11, 2015
Jkt 235001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director; Notice of Charter
Renewal
In accordance with Title 41 of the
U.S. Code of Federal Regulations,
Section 102–3.65(a), notice is hereby
given that the Charter for the Advisory
Committee to the Director, National
Institutes of Health, was renewed for an
additional two-year period on May 31,
2015.
It is determined that the Advisory
Committee to the Director, National
Institutes of Health, is in the public
interest in connection with the
performance of duties imposed on the
National Institutes of Health by law, and
that these duties can best be performed
through the advice and counsel of this
group.
Inquiries may be directed to Jennifer
Spaeth, Director, Office of Federal
Advisory Committee Policy, Office of
the Director, National Institutes of
Health, 6701 Democracy Boulevard,
Suite 1000, Bethesda, Maryland 20892
(Mail code 4875), Telephone (301) 496–
2123, or spaethj@od.nih.gov.
Dated: June 8, 2015.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–14345 Filed 6–11–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of meetings of the Board of
Scientific Counselors for Clinical
Sciences and Epidemiology, National
Cancer Institute and the Board of
Scientific Counselors for Basic Sciences,
National Cancer Institute.
The meetings will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Cancer Institute, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors for Clinical Sciences and
Epidemiology, National Cancer Institute.
Date: July 13, 2015.
Time: 9:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health, 31
Center Drive, Building 31, C-Wing, 6th Floor,
Conference Room 6, Bethesda, MD 20892.
Contact Person: Brian E. Wojcik, Ph.D.,
Executive Secretary, Institute Review Office,
Office of the Director, National Cancer
Institute, National Institutes of Health, 9609
Medical Center Drive, Room 3W414,
Rockville, MD 20850, 240–276–5660,
wojcikb@mail.nih.gov.
Name of Committee:Board of Scientific
Counselors for Basic Sciences, National
Cancer Institute.
Date: July 14, 2015.
Time: 9:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health, 31
Center Drive, Building 31, C-Wing, 6th Floor,
Conference Room 6, Bethesda, MD 20892.
Contact Person: Mehrdad Tondravi, Ph.D.,
Chief, Institute Review Office, Office of the
Director, National Cancer Institute, National
Institutes of Health, 9609 Medical Center
Drive, Room 3W302, Rockville, MD 20850,
240–276–5660, tondravim@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: June 8, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–14342 Filed 6–11–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications/
contract proposals and the discussions
E:\FR\FM\12JNN1.SGM
12JNN1
Agencies
[Federal Register Volume 80, Number 113 (Friday, June 12, 2015)]
[Notices]
[Page 33530]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-14342]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of meetings of the
Board of Scientific Counselors for Clinical Sciences and Epidemiology,
National Cancer Institute and the Board of Scientific Counselors for
Basic Sciences, National Cancer Institute.
The meetings will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Cancer Institute, including consideration of personnel qualifications
and performance, and the competence of individual investigators, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Board of Scientific Counselors for Clinical
Sciences and Epidemiology, National Cancer Institute.
Date: July 13, 2015.
Time: 9:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, 31 Center Drive, Building
31, C-Wing, 6th Floor, Conference Room 6, Bethesda, MD 20892.
Contact Person: Brian E. Wojcik, Ph.D., Executive Secretary,
Institute Review Office, Office of the Director, National Cancer
Institute, National Institutes of Health, 9609 Medical Center Drive,
Room 3W414, Rockville, MD 20850, 240-276-5660, wojcikb@mail.nih.gov.
Name of Committee:Board of Scientific Counselors for Basic
Sciences, National Cancer Institute.
Date: July 14, 2015.
Time: 9:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, 31 Center Drive, Building
31, C-Wing, 6th Floor, Conference Room 6, Bethesda, MD 20892.
Contact Person: Mehrdad Tondravi, Ph.D., Chief, Institute Review
Office, Office of the Director, National Cancer Institute, National
Institutes of Health, 9609 Medical Center Drive, Room 3W302,
Rockville, MD 20850, 240-276-5660, tondravim@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: June 8, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-14342 Filed 6-11-15; 8:45 am]
BILLING CODE 4140-01-P